Utility of suPAR and NGAL for AKI Risk Stratification and Early Optimization of Renal Risk Medications among Older Patients in the Emergency Department

Diagnosis of acute kidney injury (AKI) based on plasma creatinine often lags behind actual changes in renal function. Here, we investigated early detection of AKI using the plasma soluble urokinase plasminogen activator receptor (suPAR) and neutrophil gelatinase-sssociated lipocalin (NGAL) and obser...

وصف كامل

التفاصيل البيبلوغرافية

الحاوية / القاعدة:	Pharmaceuticals
المؤلفون الرئيسيون:	Anne Byriel Walls, Anne Kathrine Bengaard, Esben Iversen, Camilla Ngoc Nguyen, Thomas Kallemose, Helle Gybel Juul-Larsen, Baker Nawfal Jawad, Mads Hornum, Ove Andersen, Jesper Eugen-Olsen, Morten Baltzer Houlind
التنسيق:	مقال
اللغة:	الإنجليزية
منشور في:	MDPI AG 2021-08-01
الموضوعات:	acute kidney injury early biomarker plasma neutrophil gelatinase-associated lipocalin soluble urokinase plasminogen activator receptor medication optimization older patients
الوصول للمادة أونلاين:	https://www.mdpi.com/1424-8247/14/9/843